Compass Pathways reported positive results from a phase 2 study on the safety and efficacy of COMP360 psilocybin treatment for PTSD, with significant symptom improvement observed.
AI Assistant
COMPASS PATHWAYS PLC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.